Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. GLOBAL WARMING California Gov. Arnold Schwarzenegger has announced a project to reduce greenhouse gas emissions in…
Newsletter
The Competitive Enterprise Institute Daily Update
1. AUTOMOBILITY Many states are attempting to encourage ownership of hybrid powered vehicles by allowing owners driving alone to use carpool commuter…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CYBERSECURITY Advice is pouring in for the Department of Homeland Security’s as yet unnamed new…
Op-Eds
PETA or Medical Research? by Steven J. Milloy
People for the Ethical Treatment of Animals launched a campaign last week against a drug testing company for alleged violations of animal welfare laws.<?xml:namespace…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TRANSPORTATION Transportation Secretary Norman Mineta warns Amtrak that federal funds may not be available to bail…
Op-Eds
Infant Formula Ambush by Henry I. Miller
Self-styled public-health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. Activists'…